Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-234-45.

The value of benefit data in direct-to-consumer drug ads.

Author information

  • 1Veterans Affairs Outcomes Group, White River Junction, Vermont, USA. steven.woloshin@dartmouth.edu

Abstract

Direct-to-consumer (DTC) pharmaceutical ads typically describe drug benefits in qualitative terms; they rarely provide data on how well the drug works. We describe an evaluation of a "prescription drug benefit box"-data from the main randomized trials on the chances of various outcomes with and without the drug. Most participants rated the information as "very important" or "important"; almost all found the data easy to understand. Perceptions of drug effectiveness were much lower for ads that incorporated the benefit box than for ads that did not. Most people we interviewed want benefit data in drug ads, can understand these data, and are influenced by them.

Comment in

PMID:
15452006
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk